Evidence-Based Medicine Guidelines
Darbepoetin and biosimilars for the anaemia of chronic kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Darbepoetin and Biosimilars for the Anaemia of Chronic Kidney Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458245/all/Darbepoetin_and_biosimilars_for_the_anaemia_of_chronic_kidney_disease.
Darbepoetin and biosimilars for the anaemia of chronic kidney disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/458245/all/Darbepoetin_and_biosimilars_for_the_anaemia_of_chronic_kidney_disease. Accessed October 3, 2024.
Darbepoetin and biosimilars for the anaemia of chronic kidney disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/458245/all/Darbepoetin_and_biosimilars_for_the_anaemia_of_chronic_kidney_disease
Darbepoetin and Biosimilars for the Anaemia of Chronic Kidney Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458245/all/Darbepoetin_and_biosimilars_for_the_anaemia_of_chronic_kidney_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Darbepoetin and biosimilars for the anaemia of chronic kidney disease
ID - 458245
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458245/all/Darbepoetin_and_biosimilars_for_the_anaemia_of_chronic_kidney_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
